NCT01888588View on ClinicalTrials.gov

Risk of Uncomplicated Peptic Ulcer in the General Population

CompletedOBSERVATIONAL
Enrollment

4,000

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Peptic Ulcer [Iowa Type (107680.0010)]
Interventions
DRUG

Risk of symptomatic peptic ulcer

Current use of drugs (ASA; NSAIDs, SSRI,PPI, H2RA) versus non-use

Trial Locations (1)

Unknown

Research Site, Madrid

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY